Biological Age & Epigenetic Clocks
Epigenetic clocks estimate biological age from DNA methylation patterns and are among the best-validated molecular aging biomarkers: second- and third-generation clocks (PhenoAge, GrimAge) predict morbidity and mortality better than chronological age. Their key limitation is that a molecular estimate can diverge from vascular function and real-world physiological reserve — which is why Integrated Wellness assesses biological age across three independent pillars.
Written/Reviewed by: Dr. Michael Ellis, DO — Medical Director
Scientific/Technical contribution: John Campetella
Last medical review: June 2026
What methylation clocks measure
DNA methylation is a chemical modification that regulates gene expression and shifts in reproducible ways with age. Horvath's 2013 multi-tissue clock showed that a few hundred methylation sites can estimate age with remarkable accuracy across tissues. Later clocks were trained not on calendar age but on clinical phenotypes (PhenoAge) and mortality risk (GrimAge), making them more relevant to health outcomes.
Clinical relevance
Accelerated epigenetic age — a clock estimate older than chronological age — is associated with higher all-cause mortality, cardiovascular disease and functional decline in large cohorts. This makes methylation clocks useful for risk stratification and for tracking direction of change over time.
Limitations
Single-clock estimates carry technical noise between test batches; different clocks can disagree for the same person; and a favorable molecular age does not guarantee preserved vascular function or physical reserve. Interventional evidence that lowering epigenetic age causes better outcomes is still limited — clocks are best treated as biomarkers, not outcomes in themselves.
The Integrated Wellness approach
Our patent-pending Integrated Biological Age 2.0 engine runs 30+ methylation clocks in parallel for the epigenetic pillar (40% weight), then reconciles the result against an AI-derived vascular age pillar (35%) and a behavioral reserve score (25%). Divergence between pillars is treated as a clinically meaningful finding — flagged for physician review rather than averaged away.
A = consistent RCT/meta-analytic · B = strong observational/mixed · C = limited · Emerging = active research
- Horvath S (2013). DNA methylation age of human tissues and cell types. Genome Biology.
- Levine ME, et al. (2018). An epigenetic biomarker of aging for lifespan and healthspan (PhenoAge). Aging (Albany NY).
- Lu AT, et al. (2019). DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY).